Shinya Kagawa1、Chio Okuyama1、Kuninori Kusano1、Miki Ito1、Ryuichi Nishii1,2、Tatsuya Higashi1,2、Hiroshi Yamauchi1 (1.Division of PET Imaging, Shiga Medical Center Research Institute, Shiga, Japan、2.Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan)
Session information
[JSNM]Radiopharmaceuticals4: PET2
Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » [核医学]一般演題 口演
Radiopharmaceuticals4
PET1
Sun. Sep 11, 2022 9:00 AM - 9:40 AM Room6 (Kyoto International Conference Center 2F RoomB-2)
Chair:Keiichi Kawai (Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University), Shozo Furumoto (Cyclotron and Radioisotope Center, Tohoku University)
Kento Honda1、Riku Aibe1、Yuka Muranaka1、Asuka Mizutani2、Masato Kobayashi2、Keiichi Kawai2,3 (1.Division of Health Sciences, Graduate School of Medical Sciences, Kanazawa University, Ishikawa, Japan、2.Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan、3.Biomedical imaging research center, Fukui University, Hukui, Japan)
Masayuki Fujinaga1、Nobuki Nengaki1,2、Tomoteru Yamasaki1、Wakana Mori1、Katsushi Kumata1、Ming-Rong Zhang1 (1.Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quan-tum and Radiological Science and Technology, Chiba, Japan、2.SHI Accelerator Service Ltd., Tokyo, Japan)
Hirofumi Hanaoka1、Ayaka Kanai2、Yoshito Tsushima2 (1.Kansai Medical University, Hirakata, Japan、2.Gunma University Graduate School of Medicine, Maebashi, Japan)